Hirudin in the Treatment of Chronic Kidney Disease

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2024 Mar 13

PMID 38474541

Authors

Sai-Ji Liu

Yi-Ling Cao

Chun Zhang

Affiliations

Soon will be listed here.

Abstract

Chronic kidney disease (CKD) is a common public health concern. The global burden of CKD is increasing due to the high morbidity and mortality associated with it, indicating the shortcomings of therapeutic drugs at present. Renal fibrosis is the common pathology of CKD, which is characterized by glomerulosclerosis, renal tubular atrophy, and renal interstitial fibrosis. Natural hirudin is an active ingredient extracted from , which has been found to be the strongest natural specific inhibitor of thrombin. Evidence based on pharmacological data has shown that hirudin has important protective effects in CKD against diabetic nephrology, nephrotic syndrome, and renal interstitial fibrosis. The mechanisms of hirudin in treating CKD are mainly related to inhibiting the inflammatory response, preventing apoptosis of intrinsic renal cells, and inhibiting the interactions between thrombin and protease-activated receptors. In this review, we summarize the function and beneficial properties of hirudin for the treatment of CKD, and its underlying mechanisms.

Citing Articles

PGC1-Alpha/Sirt3 Signaling Pathway Mediates the Anti-Pulmonary Fibrosis Effect of Hirudin by Inhibiting Fibroblast Senescence.

He B, Zeng Q, Tian Y, Luo Y, Liao M, Huang W Biomedicines. 2024; 12(7).

PMID: 39062010 PMC: 11274105. DOI: 10.3390/biomedicines12071436.

T. gondii excretory proteins promote the osteogenic differentiation of human bone mesenchymal stem cells via the BMP/Smad signaling pathway.

Deng M, Gao F, Liu T, Zhan W, Quan J, Zhao Z J Orthop Surg Res. 2024; 19(1):386.

PMID: 38951811 PMC: 11218376. DOI: 10.1186/s13018-024-04839-0.

References

Fields W . The history of leeching and hirudin. Haemostasis. 1991; 21 Suppl 1:3-10. DOI: 10.1159/000216256. View

Pang X, Zhang Y, Shi X, Peng Z, Xing Y, Jiarui H . Hirudin Reduces the Expression of Markers of the Extracellular Matrix in Renal Tubular Epithelial Cells in a Rat Model of Diabetic Kidney Disease Through the Hypoxia-Inducible Factor-1α (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Signaling.... Med Sci Monit. 2020; 26:e921894. PMC: 7282348. DOI: 10.12659/MSM.921894. View

Liu B, Tang T, Lv L, Lan H . Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int. 2018; 93(3):568-579. DOI: 10.1016/j.kint.2017.09.033. View

Junren C, Xiaofang X, Huiqiong Z, Gangmin L, Yanpeng Y, Xiaoyu C . Pharmacological Activities and Mechanisms of Hirudin and Its Derivatives - A Review. Front Pharmacol. 2021; 12:660757. PMC: 8085555. DOI: 10.3389/fphar.2021.660757. View

Murphy S, Xu J, Kochanek K . Deaths: final data for 2010. Natl Vital Stat Rep. 2014; 61(4):1-117. View

Montinari M, Minelli S . From ancient leech to direct thrombin inhibitors and beyond: New from old. Biomed Pharmacother. 2022; 149:112878. DOI: 10.1016/j.biopha.2022.112878. View

Bruck K, Stel V, Gambaro G, Hallan S, Volzke H, Arnlov J . CKD Prevalence Varies across the European General Population. J Am Soc Nephrol. 2015; 27(7):2135-47. PMC: 4926978. DOI: 10.1681/ASN.2015050542. View

Yamashita J, Nakajima K, Ohno Y, Kaneshiro Y, Matsuo T, Tanaka H . Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats. Eur J Pharmacol. 2008; 589(1-3):239-44. DOI: 10.1016/j.ejphar.2008.04.065. View

Cha D, Kang Y, Han S, Jee Y, Han K, Han J . Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats. J Endocrinol. 2004; 183(1):183-94. DOI: 10.1677/joe.1.05647. View

10.

Nowak G . Pharmacology of recombinant hirudin. Semin Thromb Hemost. 2002; 28(5):415-24. DOI: 10.1055/s-2002-35293. View

11.

Jha J, Banal C, Chow B, Cooper M, Jandeleit-Dahm K . Diabetes and Kidney Disease: Role of Oxidative Stress. Antioxid Redox Signal. 2016; 25(12):657-684. PMC: 5069735. DOI: 10.1089/ars.2016.6664. View

12.

Markwardt F . [Isolation and chemical characterization of hirudin]. Hoppe Seylers Z Physiol Chem. 1957; 308(2-4):147-56. View

13.

Gomez G, Velarde V, Saez J . Role of a RhoA/ROCK-Dependent Pathway on Renal Connexin43 Regulation in the Angiotensin II-Induced Renal Damage. Int J Mol Sci. 2019; 20(18). PMC: 6770162. DOI: 10.3390/ijms20184408. View

14.

Cragg G, Newman D . Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 2013; 1830(6):3670-95. PMC: 3672862. DOI: 10.1016/j.bbagen.2013.02.008. View

15.

WALSMANN P . Isolation and characterization of hirudin from Hirudo medicinalis. Semin Thromb Hemost. 1991; 17(2):83-7. DOI: 10.1055/s-2007-1002593. View

16.

Greinacher A, Lubenow N, Eichler P . Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia. Circulation. 2003; 108(17):2062-5. DOI: 10.1161/01.CIR.0000096056.37269.14. View

17.

Gorecka J, Fereydooni A, Gonzalez L, Lee S, Liu S, Ono S . Molecular Targets for Improving Arteriovenous Fistula Maturation and Patency. Vasc Investig Ther. 2019; 2(2):33-41. PMC: 6788624. DOI: 10.4103/VIT.VIT_9_19. View

18.

Hetz C . The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 2012; 13(2):89-102. DOI: 10.1038/nrm3270. View

19.

Meng X, Nikolic-Paterson D, Lan H . TGF-β: the master regulator of fibrosis. Nat Rev Nephrol. 2016; 12(6):325-38. DOI: 10.1038/nrneph.2016.48. View

20.

Mills K, Xu Y, Zhang W, Bundy J, Chen C, Kelly T . A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015; 88(5):950-7. PMC: 4653075. DOI: 10.1038/ki.2015.230. View